i3 Statprobe Selected to Assume Bulk of Lilly's U.S. Data Management Work

* Reuters is not responsible for the content in this press release.

Fri Aug 8, 2008 11:39am EDT

i3 Opens Indianapolis Office to Accommodate Planned Expansion
ANN ARBOR, Mich.--(Business Wire)--
Pharmaceutical services company i3 announced today that global
pharmaceutical firm Eli Lilly and Company (NYSE: LLY) is transferring
the majority of its U.S. data management work to i3 Statprobe, a
leader in clinical data services, as part of Lilly's ongoing effort to
transform its business. This significantly expands the business
relationship between the two organizations.

   This agreement builds on i3's steady growth in functional services
outsourcing. Clients like Lilly have found that outsourcing functional
services such as data management and clinical research enhances
efficiencies and reduces cost. These benefits are critical to
customers who are competing in a changing business environment for
pharmaceutical companies.

   "i3 is pleased to be selected by a company of Lilly's stature, and
believes it reflects our fundamental commitment to the high level of
customer service that the i3 Statprobe team has provided to Lilly over
the years and our strategy of operational, clinical and scientific
specialization," said Glenn Bilawsky, i3 CEO. "We are honored to bring
this approach more broadly to a customer with the profile of Eli Lilly
and Company."

   i3 expects to hire staff from Lilly and to add additional new
positions in the Indianapolis area. i3 is scheduled to open a new
21,000 square-foot office in Indianapolis on August 18th at 4745 Haven
Point Boulevard.

   About i3

   i3, a global Ingenix company and business of UnitedHealth Group
(NYSE:UNH), provides integrated scientific strategies and solutions
throughout the pharmaceutical product lifecycle. It is composed of i3
Statprobe, a leader in comprehensive data services; i3 Research, a
therapeutically specialized contract research organization; i3 Drug
Safety, engaged in pharmacovigilance and epidemiology; i3 Pharma
Informatics, a data, science and technology provider of market
analytics; i3 Pharma Resourcing, a world-class staffing partner; and
i3 Innovus, delivering the science and solutions to achieve
marketplace success. i3 helps companies gain sharper insights that
lead to better patient care. For more information, visit
www.i3global.com.

Ingenix
Joan Schimml, 952-833-6582

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.